0001873311-21-000001.txt : 20210720
0001873311-21-000001.hdr.sgml : 20210720
20210719183347
ACCESSION NUMBER: 0001873311-21-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20210720
DATE AS OF CHANGE: 20210719
EFFECTIVENESS DATE: 20210720
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Modulus Therapeutics, Inc.
CENTRAL INDEX KEY: 0001873311
IRS NUMBER: 853561212
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-406833
FILM NUMBER: 211098912
BUSINESS ADDRESS:
STREET 1: 2101 N. 34TH ST.
STREET 2: STE.195
CITY: SEATTLE
STATE: WA
ZIP: 98103
BUSINESS PHONE: 801-534-7260
MAIL ADDRESS:
STREET 1: 2101 N. 34TH ST.
STREET 2: STE.195
CITY: SEATTLE
STATE: WA
ZIP: 98103
D
1
primary_doc.xml
X0708
D
LIVE
0001873311
Modulus Therapeutics, Inc.
2101 N. 34TH ST.
STE.195
SEATTLE
WA
WASHINGTON
98103
801-534-7260
DELAWARE
None
None
Corporation
true
2020
Bryce
R
Daines
2101 N. 34th St.
Ste. 195
Seattle
WA
WASHINGTON
98103
Executive Officer
Director
Max
C
Darnell
2101 N. 34th St.
Ste. 195
Seattle
WA
WASHINGTON
98103
Executive Officer
Director
Biotechnology
No Revenues
- 06b
false
2021-07-02
false
true
false
125000
3776000
3776000
0
false
9
0
0
0
false
Modulus Therapeutics, Inc.
Bryce R Daines
Bryce R Daines
President
2021-07-19